Vanguard Capital Management
RCEL icon

Vanguard Capital Management’s Avita Medical RCEL Stock Holding History

Vanguard Capital Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.51M Sell
1,333,914
-1,238
-0.1% -$5.34K ﹤0.01% 3083
2026
Q1 		$4.94M Buy
+1,335,152
New +$5.61M ﹤0.01% 3063

Other funds holding RCEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Vanguard Capital Management's RCEL Position: Q2 2026 in Review

Vanguard Capital Management reduced its Avita Medical (RCEL) stake by 0.09% in Q2 2026, selling an estimated $5.34K and leaving 1,333,914 shares worth $5.51M. The position accounts for ﹤0.01% of the portfolio, ranked #3083.

Vanguard Capital Management first reported a position in RCEL in Q1 2026 and has held it in 2 quarters since. 73 funds tracked by Wall St. Rank hold RCEL as of Q2 2026.

  • Vanguard Capital Management held 1,333,914 shares of Avita Medical worth $5.51M as of Q2 2026.
  • Vanguard Capital Management sold 1,238 Avita Medical shares in Q2 2026, an estimated $5.34K.
  • Avita Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3083 holding.
  • Vanguard Capital Management first reported a position in Avita Medical in Q1 2026 and has held it in 2 quarters since.
  • 73 funds tracked by Wall St. Rank held Avita Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.